Table 1 Total clinical characteristics
From: Ovarian endometrioid carcinoma and clear cell carcinoma: A 21-year retrospective study
Clinicopathological Factor | Number(%)/Median(P25,P75) |
|---|---|
EC | 73 (34.6%) |
CCC | 91 (43.1%) |
Mix | 47 (22.3%) |
Mixed with EC | 31 (14.7%) |
Mixed with CCC | 13 (6.2%) |
Both | 3 (1.4%) |
EMs in Pathological Section | 114 (54.0%) |
Past History of EMs | 16 (7.6%) |
Endometrial cancer | 26 (12.3%) |
Concurrent with pure EC | 23 (10.9%) |
Concurrent with pure CCC | 1 (0.47) |
Parity | |
  > 1 | 170 (80.6%) |
 0 | 41 (19.4%) |
 Past History of Hypertension | 46 (21.8%) |
 Past History of Diabetes | 18 (8.5%) |
 Overweight (BMI > 24) | 89 (42.4%) |
 Dysmenorrhea | 49 (23.2%) |
 Post-menopause | 101 (47.9%) |
 Breast cancer | 8 (3.8%) |
 Immune System Disease | 7 (3.3%) |
Initial Signs/Symptoms | |
 Abdominal Pain | 42 (19.9%) |
 Abdominal Distension | 40 (19.0%) |
 Abdominal Mass | 17 (8.1%) |
 Asymptomatic | 68 (32.2%) |
 Vaginal Bleeding | 15 (7.1%) |
 Painful Menstruation | 2 (0.92%) |
 Othersa | 27 (12.8%) |
CA-125 levelb | |
 Pre-operation | 96.0 (31.4, 378.0) |
 Post-operation | 42.5 (19.1, 99.34) |